The purpose of this study is to examine the safety and toleration of PEP005 Topical Gel, administered on an actinic keratosis (AK) treatment area on the top of a hand.
Actinic keratoses (AK) is a common skin condition characterized by rough, scaly patches or sores on the top layer of the skin which if left untreated can progress to skin cancer. Current treatments can cause scarring and hypopigmentation, be inconvenient, or require long treatment duration. Non-invasive alternative therapy for treatment of AK lesions is thus being researched.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
12
Two day application, 0.05%
Skin Surgery Medical Group Inc
San Diego, California, United States
Gwinnett Clinical Research Centre
Snellville, Georgia, United States
Dermatology Clinical Research Centre of San Antonio
San Antonio, Texas, United States
Dermatology Associates of Tyler
Tyler, Texas, United States
Incidence of Adverse Events (AEs) and Serious Adverse Events (SAEs); and Local Skin Responses (LSR)
Time frame: 57 days
The complete clearance rate of AK lesions; partial clearance rate of AK lesions and baseline clearance rate of AK lesions.
Time frame: 57 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.